| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |